Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Claims tied to non-prescription peptides' fat-loss benefits are often made without a cited study behind them, which makes their real-world results harder to predict than those of FDA-approved options
This approach, guided by regular blood testing, can optimize both effectiveness and cost-efficiency
The product will not be used for diagnostic, therapeutic, or medicinal purposes
The 2022 Dimet-Wiley paper in Scientific Reports characterised NNMT inhibition combined with reduced-calorie diet in diet-induced-obesity mouse model systems (PMID 35013352)
Archived from the original on 16 November 2019
US$ 28.44
US$ 23.64
US$ 28.14
US$ 26.28
